NDC 25021-207 – Doxorubicin hydrochloride
Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Intravenous
Product NDC25021-207
Product details
- Brand name
- Doxorubicin hydrochloride
- Generic name
- Doxorubicin hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA209825
- Marketed since
- October 31, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 25021-207-25 | 1 VIAL in 1 CARTON (25021-207-25) / 25 mL in 1 VIAL | Oct 31, 2013 |
| 25021-207-51 | 1 VIAL in 1 CARTON (25021-207-51) / 100 mL in 1 VIAL | Oct 31, 2013 |
Other Doxorubicin Hydrochloride products
- 45963-733 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 63323-101 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-883 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-248 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-249 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-250 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Gland Pharma Limited
- 0143-9090 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9091 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9088 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9084 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9085 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9086 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.